Table: Santen Pharm -2016/17 parent results

SANTEN PHARMACEUTICAL

10/05/2017 07:00

May 10 (Reuters)-  
          Santen Pharmaceutical Co Ltd  
          PARENT-ONLY FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                   Year ended      Year ended       Year to       NEXT    
                Mar 31, 2017    Mar 31, 2016   Mar 31, 2018     YEAR      
                   LATEST         YEAR-AGO        COMPANY      COMPANY    
                   RESULTS         RESULTS       FORECAST    H1 FORECAST  
  Sales            156.97          156.12                                 
                 (+0.5 pct)      (+12.8 pct)                              
  Operating         31.31           30.71                                 
                 (+1.9 pct)      (-7.5 pct)                               
  Recurring         30.38           30.55                                 
                 (-0.6 pct)      (-9.8 pct)                               
  Net               25.00           51.45                                 
                 (-51.4 pct)    (+128.9 pct)                              
  EPS             60.92 yen      124.35 yen                               
  EPS Diluted     60.70 yen      123.79 yen                               
  Ann Div         26.00 yen       25.00 yen      26.00 yen                
  -Q2 Div         13.00 yen       12.00 yen      13.00 yen                
  -Q4 Div         13.00 yen       13.00 yen      13.00 yen                
   
  NOTE - Santen Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4536.T 
  ((Tokyo Headline News Desk +813 6441 1812))